| scholarly article | Q13442814 |
| P50 | author | Nora M Chapman | Q49527410 |
| P2093 | author name string | Kristen M Drescher | |
| Steven Tracy | |||
| Kuniyuki Oka | |||
| Kyung-Soo Kim | |||
| P2860 | cites work | Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart | Q23917803 |
| Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification | Q24517799 | ||
| 5' cloverleaf in poliovirus RNA is a cis-acting replication element required for negative-strand synthesis | Q24545690 | ||
| Viral myocarditis. A review | Q24682597 | ||
| Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor | Q27635031 | ||
| Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension | Q29547330 | ||
| From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future | Q33537451 | ||
| Cleavage of Poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff? | Q33639744 | ||
| Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. | Q33639759 | ||
| 3'-Terminal sequence in poliovirus negative-strand templates is the primary cis-acting element required for VPgpUpU-primed positive-strand initiation | Q33737625 | ||
| 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. | Q33788804 | ||
| Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution | Q33825114 | ||
| Poliovirus 5'-terminal cloverleaf RNA is required in cis for VPg uridylylation and the initiation of negative-strand RNA synthesis | Q33848778 | ||
| Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. | Q33855715 | ||
| Primer-dependent synthesis by poliovirus RNA-dependent RNA polymerase (3D(pol)). | Q33940127 | ||
| Typing of human enteroviruses by partial sequencing of VP1. | Q33960048 | ||
| An authentic 3' noncoding region is necessary for efficient poliovirus replication | Q33987475 | ||
| The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review | Q34219414 | ||
| Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. | Q34359584 | ||
| The group B coxsackieviruses and myocarditis | Q34464947 | ||
| Echovirus 11 infections of newborns with mortality during the 1979 enterovirus season in Milwaukee, Wis | Q34505541 | ||
| Coxsackievirus experimental heart diseases | Q35011233 | ||
| Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens | Q35073068 | ||
| Cell-dependent role for the poliovirus 3' noncoding region in positive-strand RNA synthesis | Q35542907 | ||
| Replication of poliovirus RNA with complete internal ribosome entry site deletions | Q35542921 | ||
| Myocarditis and dilated cardiomyopathy An inflammatory link | Q35548716 | ||
| Transformation of myocarditis and inflammatory cardiomyopathy to idiopathic dilated cardiomyopathy: facts and fiction | Q35574572 | ||
| A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperature-sensitive | Q35595139 | ||
| Structure of the 5' nontranslated region of the coxsackievirus b3 genome: Chemical modification and comparative sequence analysis | Q35634916 | ||
| Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients | Q35691070 | ||
| Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis | Q35896244 | ||
| Ohio strains of a virus pathogenic for infant mice, Coxsackie group; simultaneous occurrence with poliomyelitis virus in patients with summer grippe | Q36261307 | ||
| Deletions within the 5'UTR of coxsackievirus B3: consequences for virus translation and replication | Q36359523 | ||
| Autoimmunity in coxsackievirus B3 induced myocarditis | Q36385481 | ||
| Viruses as quasispecies: biological implications | Q36433889 | ||
| Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions | Q36483302 | ||
| Recombination in circulating enteroviruses | Q36525069 | ||
| Idiopathic dilated cardiomyopathy as a late complication of healed viral (Coxsackie B virus) myocarditis: historical analysis, review of the literature, and a postulated unifying hypothesis | Q36546874 | ||
| Isolation of a Coxsackie virus group B, type 5, from the heart of a fatal case of myocarditis in an adult | Q36550286 | ||
| Involvement of cellular membrane traffic proteins in poliovirus replication | Q36716351 | ||
| Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation | Q36771022 | ||
| Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis | Q36828203 | ||
| An RNA sequence of hundreds of nucleotides at the 5' end of poliovirus RNA is involved in allowing viral protein synthesis | Q36871639 | ||
| Restriction of translation of capped mRNA in vitro as a model for poliovirus-induced inhibition of host cell protein synthesis: relationship to p220 cleavage | Q36916290 | ||
| Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy | Q37115645 | ||
| Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization | Q37182343 | ||
| Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy | Q37385438 | ||
| A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice | Q39590726 | ||
| Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis | Q39591989 | ||
| Coxsackievirus infections of the newborn | Q39925444 | ||
| Improved method for detecting poliovirus negative strands used to demonstrate specificity of positive-strand encapsidation and the ratio of positive to negative strands in infected cells | Q40065080 | ||
| Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma. | Q40116917 | ||
| Nested PCR for specific detection and rapid identification of human picornaviruses. | Q40175553 | ||
| Shutoff of RNA polymerase II transcription by poliovirus involves 3C protease-mediated cleavage of the TATA-binding protein at an alternative site: incomplete shutoff of transcription interferes with efficient viral replication | Q40398033 | ||
| Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection | Q40497673 | ||
| Fulminant myocarditis demonstrating uncommon morphology--a report of two autopsy cases. | Q40516383 | ||
| Cleavage of poly(A)-binding protein by poliovirus 3C protease inhibits host cell translation: a novel mechanism for host translation shutoff | Q40583503 | ||
| A molecular and serologic evaluation of enteroviral involvement in human myocarditis | Q41201024 | ||
| End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response | Q41852946 | ||
| Typing of human enterovirus by partial sequencing of VP2. | Q41906944 | ||
| Coxsackie B virus infection of the newborn. | Q42414273 | ||
| Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products | Q43504047 | ||
| Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy | Q43726218 | ||
| Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction | Q43738844 | ||
| Isolation and type determination of Coxsackie virus, group B, in tissue culture | Q44231257 | ||
| Genomic and phylogenetic characterization of coxsackievirus B2 prototype strain Ohio-1. | Q44642550 | ||
| Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes | Q46824408 | ||
| Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate | Q48159218 | ||
| A functional ribonucleoprotein complex forms around the 5' end of poliovirus RNA. | Q52483547 | ||
| Viral persistence in the myocardium is associated with progressive cardiac dysfunction. | Q52936642 | ||
| PERICARDITIS INFECTION DUE TO COXSACKIE VIRUS GROUP B, TYPE 2. | Q55412243 | ||
| Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy | Q59461275 | ||
| Fatal coxsackievirus B4 infection in a neonate | Q70103054 | ||
| X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus | Q70743324 | ||
| The structure of coxsackievirus B3 at 3.5 A resolution | Q70976276 | ||
| Enteroviral RNA in dilated cardiomyopathy | Q72715829 | ||
| Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease | Q73093797 | ||
| Localization of enteroviral antigen in myocardium and other tissues from patients with heart muscle disease by an improved immunohistochemical technique | Q73685161 | ||
| Detection of enteroviruses ribonucleic acid sequences in endomyocardial tissue from adult patients with chronic dilated cardiomyopathy by a rapid RT-PCR and hybridization assay | Q73897210 | ||
| Enteroviruses can persist with or without active viral replication in cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy | Q74296064 | ||
| Unusual case of viral pericarditis | Q93696669 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Coxsackievirus | Q1138287 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 480-491 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | 5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart | |
| P478 | volume | 375 |
| Q58795956 | Amplification and next generation sequencing of near full-length human enteroviruses for identification and characterisation from clinical samples |
| Q38090473 | Caspase-8 and FLIP regulate RIG-I/MDA5-induced innate immune host responses to picornaviruses |
| Q36216936 | Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes |
| Q102144637 | Coxsackievirus B Type 4 Infection in β Cells Downregulates the Chaperone Prefoldin URI to Induce a MODY4-like Diabetes via Pdx1 Silencing |
| Q50194551 | Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes |
| Q39138391 | Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates. |
| Q42200757 | Coxsackievirus can persist in murine pancreas by deletion of 5' terminal genomic sequences |
| Q36507273 | Direct Identification of Enteroviruses in Cerebrospinal Fluid of Patients with Suspected Meningitis by Nested PCR Amplification. |
| Q38764946 | Domain I of the 5' non-translated genomic region in coxsackievirus B3 RNA is not required for productive replication. |
| Q52655516 | Emergency Services of Viral RNAs: Repair and Remodeling. |
| Q57933427 | Enteroviral infections in the pathogenesis of type 1 diabetes: new insights for therapeutic intervention |
| Q38825350 | Enteroviral proteases: structure, host interactions and pathogenicity. |
| Q90176612 | Enterovirus and Encephalitis |
| Q40473878 | Enterovirus but not Parvovirus B19 is associated with idiopathic dilated cardiomyopathy and endomyocardial CD3, CD68, or HLA-DR expression. |
| Q33751633 | Enteroviruses as a possible cause of hypertension, dilated cardiomyopathy (DCM) and hypertensive heart failure (HHF) in South western Nigeria. |
| Q37737983 | Enteroviruses in the pathogenesis of type 1 diabetes |
| Q28276366 | Environmental risk factors for type 1 diabetes |
| Q57920473 | Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1 |
| Q40187551 | Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation |
| Q84518549 | Functional role of the 5' terminal cloverleaf in Coxsackievirus RNA replication |
| Q37254324 | Human astrocytic cells support persistent coxsackievirus B3 infection |
| Q41929925 | Immunological and pathological consequences of coxsackievirus RNA persistence in the heart |
| Q37990025 | Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma |
| Q35483420 | Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy |
| Q97595668 | Major 5'terminally deleted enterovirus populations modulate type I IFN response in acute myocarditis patients and in human cultured cardiomyocytes |
| Q40643308 | Major Persistent 5' Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues |
| Q36281122 | Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions. |
| Q35952020 | Neural stem cell depletion and CNS developmental defects after enteroviral infection |
| Q40361991 | Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes. |
| Q92756042 | Persistent Infection and Transmission of Senecavirus A from Carrier Sows to Contact Piglets |
| Q42147573 | Prior immune exposure can protect or can enhance pathology in the enteroviruses: what predicts the outcome? |
| Q42691275 | Quantitative genomic and antigenomic enterovirus RNA detection in explanted heart tissue samples from patients with end-stage idiopathic dilated cardiomyopathy. |
| Q36052773 | Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis |
| Q40693212 | Reversion to wildtype of a mutated and nonfunctional coxsackievirus B3CRE(2C). |
| Q41437245 | The Role of Epigenetics in Type 1 Diabetes |
| Q54242424 | The Roles of Picornavirus Untranslated Regions in Infection and Innate Immunity. |
| Q27026794 | The microbiology of human hygiene and its impact on type 1 diabetes |
| Q39405656 | Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas. |
| Q34608956 | Type B Coxsackieviruses and Their Interactions with the Innate and Adaptive Immune Systems |
| Q37876416 | Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection |
Search more.